# World

Indonesia approves emergency use of Chinese vaccine

Previously, Indonesia had approved the emergency use for three other brands of Covid-19 vaccines.

IANS | April 30, 2021 1:26 pm

Indonesia approves emergency use of Chinese vaccine

Indonesia’s food and drug authority BPOM has issued an emergency use authorisation (EUA) for the Covid-19 vaccine produced by Chinese pharmaceutical company Sinopharm, an official source said on Friday.

Chief of BPOM Penny Lukito made the announcement, saying the issuance of the EUA was based on the third phase of clinical trials in the United Arab Emirates and other countries, the Xinhua news agency reported.

Indonesia would use the Sinopharm vaccine for a mutual vaccination scheme locally known as “Gotong Royong”, where companies or legal entities can arrange the Covid-19 vaccine rollout for their employees for free, to help the country achieve herd immunity faster.

Previously, Indonesia had approved the emergency use for three other brands of Covid-19 vaccines, namely the CoronaVac produced by the Chinese company Sinovac, the Covid-19 vaccine produced by the state-company PT Bio Farma in collaboration with Sinovac, and the AstraZeneca vaccine.

# Opinion

Policy balance

The recent appointment of Sanjay Malhotra as Governor of the Reserve Bank of India (RBI), replacing Shaktikanta Das, signals a pivotal shift in India’s monetary policy dynamics.

# Sports

Rewind 2024: India’s bittersweet campaign in Paris

Last minute preparations, exposure camps abroad, TOPs funding, overlooking administrative mess-ups to pick the crème de la crème of Indian sports for the biggest show on earth that unfolded in Paris three years after COVID-19 pushed the Tokyo edition of the Olympics by a year.

# India